Author:
Zhang Yonggang,He Jie,Deng Yao,Zhang Jie,Li Xiaobo,Xiang Zhangpeng,Huang Honglang,Tian Can,Huang Jin,Fan Hong
Abstract
Abstract
Background
The insertion/deletion (I/D) polymorphism in the Angiotensin-converting enzyme (ACE) gene has been implicated in susceptibility to cancer, but a large number of studies have reported inconclusive results. The aim of this study is to assess the association between the I/D polymorphism in the ACE gene and cancer risk by meta-analysis.
Methods
A search was performed in Pubmed database, Embase database, Chinese Biomedical (CBM) database, China National Knowledge Infrastructure (CNKI) database and Weipu database, covering all studies until August 31, 2010. Statistical analysis was performed by using Revman4.2 and STATA 10.0.
Results
A total of 25 case-control studies comprising 3914 cancer patients and 11391 controls were identified. No significant association was found between the I/D polymorphism and over all cancer risks (OR = 0.88, 95%CI = 0.73-1.06, P = 0.17 for DD+DI vs. II). In the subgroup analysis by ethnicity, no significant association was found among Asians and Europeans for the comparison of DD+DI vs. II. In the subgroup analysis by cancer types, no significant associations were found among lung cancer, breast cancer, prostate cancer, colorectal cancer, gastric cancer for the comparison of DD+DI vs. II. Results from other comparative genetic models also indicated the lack of associations between this polymorphism and cancer risks.
Conclusions
This meta-analysis suggested that the ACE D/I polymorphism might not contribute to the risk of cancer.
Publisher
Springer Science and Business Media LLC
Subject
Genetics(clinical),Genetics
Reference50 articles.
1. Eriksson U, Danilczyk U, Penninger JM: Just the beginning: novel functions for angiotensin-converting enzymes. Curr Biol. 2002, 12: R745-R752. 10.1016/S0960-9822(02)01255-1.
2. Vairaktaris E, Yapijakis C, Tsigris C, Vassiliou S, Derka S, Nkenke E, Spyridonidou S, Vylliotis A, Vorris E, Ragos V, et al: Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with increased risk for oral cancer. Acta Oncol. 2007, 46: 1097-1102. 10.1080/02841860701373579.
3. Nacak M, Nacak I, Sanli M, Ozkur M, Pektas M, Aynacioglu AS: Association of angiotensin converting enzyme gene insertion/deletion polymorphism with lung cancer in Turkey. Cancer Genet Cytogenet. 2010, 198: 22-26. 10.1016/j.cancergencyto.2009.11.019.
4. Sugimoto M, Furuta T, Shirai N, Ikuma M, Sugimura H, Hishida A: Influences of chymase and angiotensin I-converting enzyme gene polymorphisms on gastric cancer risks in Japan. Cancer Epidemiol Biomarkers Prev. 2006, 15: 1929-1934. 10.1158/1055-9965.EPI-06-0339.
5. Yigit B, Bozkurt N, Narter F, Yilmaz H, Yucebas E, Isbir T: Effects of ACE I/D polymorphism on prostate cancer risk, tumor grade and metastatis. Anticancer Res. 2007, 27: 933-936.